Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapyChen Yang, Cun Wang, Haigang Geng et al.|Cancer Cell|2024Cited by 70
Multivalent aptamer engineered and functionalized NK cells for enhanced adoptive immunotherapy in CD30-positive malignant lymphomaFang Tan, Qian Li, Xuyang Zhao et al.|Molecular Therapy — Nucleic Acids|2025Cited by 3